Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Breast Cancer Research and Treatment|October 17, 2023
Evaluation of the international Ki67 working group cut point recommendations for early breast cancer: comparison with 21-gene assay results in a large integrated health care systemVeronica C Shim, Robin J Baker, Wen Jing, et al.
Scientific Data|March 5, 2026
WxC-Bench: A Novel Dataset for Weather and Climate Downstream TasksRajat Shinde, Kumar Ankur, Christopher E Phillips, et al.
Molecular Psychiatry|July 27, 2022
Longitudinal trajectories of cortical development in 22q11.2 copy number variants and typically developing controlsMaria Jalbrzikowski, Amy Lin, Ariana Vajdi, et al.
Pharmacoeconomics|March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis CJens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Gastroenterology|July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirinMark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Combined alloreactive CTL cellular therapy with prodrug activator gene therapy in a model of breast cancer metastatic to the brainMichelle J Hickey, Colin C Malone, Kate L Erickson, et al.
The New England Journal of Medicine|September 27, 2002
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infectionMichael W Fried, Mitchell L Shiffman, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 12, 2013
Depressive symptoms in Chinese-American subjects with cognitive impairmentSteven Z Chao, Brandy R Matthews, Jennifer S Yokoyama, et al.
Pageof 26